Justin S Trory

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Histone Deacetylase

Top Venues

RSC medicinal chemistry

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Megan F Allen, James L Hutchinson, Michael Keith, Shahida Mallah, Robin Adam Corey, Justin S Trory, Changcheng Jing, Huaquan Fang, Liang Wei, Steven H Bennett, Varinder Kumar Aggarwal, Stuart J Mundell, Ingeborg Hers
Difluorinated thromboxane A 2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. British journal of pharmacology (2024)
Megan F Allen, James L Hutchinson, Michael Keith, Shahida Mallah, Robin Adam Corey, Justin S Trory, Changcheng Jing, Huaquan Fang, Liang Wei, Steven H Bennett, Varinder Kumar Aggarwal, Stuart J Mundell, Ingeborg Hers
Difluorinated thromboxane A 2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. British journal of pharmacology 181 (19) (2024)
Jasmine M Cross, Megan E Coulson, Joshua P Smalley, Wiktoria A Pytel, Ozair Ismail, Justin S Trory, Shaun M Cowley, James T Hodgkinson
A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras. RSC medicinal chemistry 13 (12) (2022)
Justin S Trory, Attila Munkacsi, Kamila Malwina Śledź, Jordan Vautrinot, Lucy J Goudswaard, Molly L Jackson, Kate J Heesom, Samantha F Moore, Alastair W Poole, Behnam Nabet, Varinder K Aggarwal, Ingeborg Hers
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function. Blood advances (2022)
Jasmine M Cross, Megan E Coulson, Joshua P Smalley, Wiktoria A Pytel, Ozair Ismail, Justin S Trory, Shaun M Cowley, James T Hodgkinson
A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras. RSC medicinal chemistry 13 (12) (2022)